Angie Drakulich
Advertisement
Angie Drakulich was editorial director of BioPharm International.
Articles by Angie Drakulich
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Merck TROP2 ADC Meets Survival End Point in Gastroesophageal Cancer
2
The BioPharm Brief: A Matrix-Targeting ADC in Head and Neck Cancer, an RNAi Approval in Myasthenia Gravis, and AbbVie Bets on AND-Gated Bispecifics
3
Evotec, BMS Gain Second FDA IND Acceptance for Molecular Glue Degrader
4
Pyxis’ Matrix-Targeting ADC MICVO Shows 39% Response Rate and 9.2-Month Median Response Duration in Previously Treated Head and Neck Cancer
5

